Detalhe da pesquisa
1.
Spray-type modifications: an emerging paradigm in post-translational modifications.
Trends Biochem Sci
; 49(3): 208-223, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38443288
2.
Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study.
Hepatology
; 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38466796
3.
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B.
Gut
; 73(4): 649-658, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37813567
4.
Extrahepatic malignancies in metabolic dysfunction-associated fatty liver disease: A nationwide cohort study.
Liver Int
; 44(3): 799-810, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38230848
5.
Risk of hepatocellular carcinoma after curative treatment when switching from tenofovir disoproxil fumarate or entecavir to tenofovir alafenamide: A real-world multicenter cohort study.
Hepatol Res
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300711
6.
Effectiveness of US Surveillance of Hepatocellular Carcinoma in Chronic Hepatitis B: US LI-RADS Visualization Score.
Radiology
; 307(5): e222106, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249427
7.
Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis.
Hepatology
; 76(2): 492-501, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35100447
8.
Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study.
BMC Gastroenterol
; 23(1): 210, 2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322445
9.
Efficacy of Antiviral Prophylaxis up to 6 or 12 Months From Completion of Rituximab in Resolved Hepatitis B Patients: A Multicenter, Randomized Study.
J Korean Med Sci
; 38(28): e216, 2023 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463687
10.
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
J Hepatol
; 76(2): 311-318, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34606915
11.
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 20(6): 1343-1353.e16, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34500103
12.
Association of Metabolic Risk Factors With Risks of Cancer and All-Cause Mortality in Patients With Chronic Hepatitis B.
Hepatology
; 73(6): 2266-2277, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140415
13.
Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection.
Liver Int
; 42(2): 320-329, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34679254
14.
Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysis.
BMC Gastroenterol
; 22(1): 135, 2022 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35337274
15.
A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC.
Dig Dis Sci
; 67(1): 329-336, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538921
16.
Effectiveness of Lenvatinib Versus Sorafenib for Unresectable Hepatocellular Carcinoma in Patients with Hepatic Decompensation.
Dig Dis Sci
; 67(10): 4939-4949, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35048224
17.
Entecavir Plus Pegylated Interferon and Sequential Hepatitis B Virus Vaccination Increases Hepatitis B Surface Antigen Seroclearance: A Randomized Controlled Proof-of-Concept Study.
Clin Infect Dis
; 73(9): e3308-e3316, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32556157
18.
Empirical Treatment With Carbapenem vs Third-generation Cephalosporin for Treatment of Spontaneous Bacterial Peritonitis.
Clin Gastroenterol Hepatol
; 19(5): 976-986.e5, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32623007
19.
Quantitative Assessment of Fatty Liver using Ultrasound with Normalized Local Variance Technique.
Ultraschall Med
; 42(6): 599-606, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32323278
20.
CKD-5, a novel pan-histone deacetylase inhibitor, synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma.
BMC Cancer
; 20(1): 1001, 2020 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33059615